These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2154781)

  • 21. Effect of cholera toxin and pertussis toxin on opioid tolerance and dependence in the guinea-pig myenteric plexus.
    Lux B; Schulz R
    J Pharmacol Exp Ther; 1986 Jun; 237(3):995-1000. PubMed ID: 3012078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-opioid receptor adaptations to chronic morphine; altered functionality and associations of signaling molecules.
    Gintzler AR; Chakrabarti S
    Life Sci; 2006 Jul; 79(8):717-22. PubMed ID: 16581089
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic morphine augments G(beta)(gamma)/Gs(alpha) stimulation of adenylyl cyclase: relevance to opioid tolerance.
    Chakrabarti S; Rivera M; Yan SZ; Tang WJ; Gintzler AR
    Mol Pharmacol; 1998 Oct; 54(4):655-62. PubMed ID: 9765508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mu-opioid receptor-mediated inhibition of D-1 dopamine receptor stimulated adenylate cyclase in primary cultures of rat neostriatal neurons.
    van Vliet BJ; Mulder AH; Schoffelmeer AN
    Prog Clin Biol Res; 1990; 328():409-12. PubMed ID: 2154799
    [No Abstract]   [Full Text] [Related]  

  • 25. Cross-tolerance between mu- and kappa-opioid agonists in the guinea pig ileum myenteric plexus.
    Garaulet JV; Laorden ML; Milanés MV
    J Pharmacol Exp Ther; 1994 Jun; 269(3):993-9. PubMed ID: 8014886
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lobeline, a potential pharmacotherapy for drug addiction, binds to mu opioid receptors and diminishes the effects of opioid receptor agonists.
    Miller DK; Lever JR; Rodvelt KR; Baskett JA; Will MJ; Kracke GR
    Drug Alcohol Depend; 2007 Jul; 89(2-3):282-91. PubMed ID: 17368966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mu- and delta-opioid receptor-mediated inhibition of adenylate cyclase activity stimulated by released endogenous dopamine in rat neostriatal slices; demonstration of potent delta-agonist activity of bremazocine.
    Heijna MH; Hogenboom F; Portoghese PS; Mulder AH; Schoffelmeer AN
    J Pharmacol Exp Ther; 1989 Jun; 249(3):864-8. PubMed ID: 2543814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. mu-Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase but enhance dopamine-stimulated activity of type VII adenylyl cyclase.
    Yoshimura M; Ikeda H; Tabakoff B
    Mol Pharmacol; 1996 Jul; 50(1):43-51. PubMed ID: 8700117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. On the mechanism of receptor-mediated inhibition of adenylate cyclase.
    Klee WA; Koski G; Tocque B; Simonds WF
    Adv Cyclic Nucleotide Protein Phosphorylation Res; 1984; 17():153-9. PubMed ID: 6145318
    [No Abstract]   [Full Text] [Related]  

  • 30. Supersensitivity to mu-opioid receptor-mediated inhibition of the adenylyl cyclase pathway involves pertussis toxin-resistant Galpha protein subunits.
    Mostany R; Díaz A; Valdizán EM; Rodríguez-Muñoz M; Garzón J; Hurlé MA
    Neuropharmacology; 2008 May; 54(6):989-97. PubMed ID: 18384820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of receptor regulation in opioid tolerance mechanisms.
    Loh HH; Tao PL; Smith AP
    Synapse; 1988; 2(4):457-62. PubMed ID: 2847342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of G(i)alpha2-protein in opioid tolerance and mu-opioid receptor downregulation in vivo.
    Yoburn BC; Gomes BA; Rajashekara V; Patel C; Patel M
    Synapse; 2003 Feb; 47(2):109-16. PubMed ID: 12454948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Basal signaling activity of mu opioid receptor in mouse brain: role in narcotic dependence.
    Wang D; Raehal KM; Lin ET; Lowery JJ; Kieffer BL; Bilsky EJ; Sadée W
    J Pharmacol Exp Ther; 2004 Feb; 308(2):512-20. PubMed ID: 14600246
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioid-dependent dual regulation of adenylate cyclase in a cell-free system.
    Klee WA; Streaty RA
    Adv Cyclic Nucleotide Res; 1981; 14():629-35. PubMed ID: 6269403
    [No Abstract]   [Full Text] [Related]  

  • 35. [Morphine receptors and their ligands].
    Jacob J; Fillion G
    Actual Pharmacol (Paris); 1978; 30():113-58. PubMed ID: 28638
    [No Abstract]   [Full Text] [Related]  

  • 36. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
    Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
    J Pharmacol Exp Ther; 1987 Jan; 240(1):150-8. PubMed ID: 3027302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic morphine induces tolerance and desensitization of mu-opioid receptor but not down-regulation in rabbit.
    Polastron J; Meunier JC; Jauzac P
    Eur J Pharmacol; 1994 Jan; 266(2):139-46. PubMed ID: 8157068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control of opiate receptor-adenylate cyclase interactions by calcium ions and guanosine-5'-triphosphate.
    Wilkening D; Sabol SL; Nirenberg M
    Brain Res; 1980 May; 189(2):459-66. PubMed ID: 6245765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An investigation of the N-demethylation of 3-deoxymorphine and the affinity of the alkylation products to mu, delta, and kappa receptors.
    Csutoras C; Zhang A; Bidlack JM; Neumeyer JL
    Bioorg Med Chem; 2004 May; 12(10):2687-90. PubMed ID: 15110850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of adenylate cyclase by GTP and its modulation by opiate receptor in rat caudate nucleus.
    Kamikubo K; Nozaki M; Fujimura H
    Jpn J Pharmacol; 1981 Apr; 31(2):175-84. PubMed ID: 6273623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.